ErbB4 and its isoformsselective regulation of growth factor responses by naturally occurring receptor variants

Trends in Cardiovascular Medicine

Volumn 10, Issue 7, 2000, Pages 304-310

  Junttila, Teemu T ^a   Sundvall, Maria ^a   Määttä, Jorma A ^a   Elenius, Klaus ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; METALLOPROTEINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH FACTOR RECEPTOR; ISOPROTEIN; LIGAND; PROTEIN TYROSINE KINASE;

CANCER; CARDIOVASCULAR DISEASE; CHEMOTAXIS; DIMERIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; PROTEIN ISOFORMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; VARIATION (GENETICS);

EID: 0034351216     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00065-2     Document Type: Review

References (60)

1. The ErbB signaling network in embryogenesis and oncogenesis; signal diversification through combinatorial ligand-receptor interactions
2. Vascular endothelial growth factor upregulation via p21-activated kinase-1 signaling regulates heregulin-b1-mediated angiogenesis
3. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired
4. Neuregulins and their receptors; a versatile signaling module in organogenesis and oncogenesis
5. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
6. The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells
7. The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor
8. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms
9. Heterodimerization and functional interaction between EGF receptor family members; a new signaling paradigm with implications for breast cancer research
10. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
11. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester
12. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
13. Extracellular domains drive homo- but not hetero-dimerization of erbB receptors
14. Aria; a neuromuscular junction neuregulin
15. PI3k; downstream Aktion blocks apoptosis
16. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40
17. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
18. Expression and characterization of ErbB4 and ErbB2 alternatively spliced variants by childhood medulloblastoma primary tumors
19. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma
20. Neuregulin-4; a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
21. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas
22. Signaling pathways for cardiac hypertrophy and failure
23. The biology of erbB-2/neu/HER-2 and its role in cancer
24. Structural and functional diversity in the FGF receptor multigene family
25. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites
26. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation
27. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis
28. The ErbB/HER family of receptor tyrosine kinases; A potential target for chemoprevention of epithelial neoplasms
29. A novel splice variant of HER2 with increased transformation activity
30. Requirement for neuregulin receptor erbB2 in neural and cardiac development
31. New EMBO members' review; the ErbB signaling network: receptor heterodimerization in development and cancer
32. A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue
33. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
34. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4
35. Specificity within the EGF family/ErbB receptor family signaling network
36. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
37. Neuregulin in cardiac hypertrophy in rats with aortic stenosis
38. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis
39. Two erbB4 transcripts are expressed in normal breast and in most breast cancers
40. A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells
41. TM (humanized anti-HER2 antibody) to first line chemotherapy for HER2 overexpressing metastatic breast cancer (HER2+/MBC) markedly increases anticancer activity; a randomzied, multinational controlled phase III trial
42. Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers
43. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
44. A genetic blueprint for cardiac development
45. Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo
46. Signalling through the lipid products of phosphoinositide-3-OH kinase
47. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
48. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation
49. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism
50. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin
51. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer
52. Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stage-specific activation of calcium influx by ErbB receptors in developing mouse blastocysts
53. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3′ kinase
54. Structural alterations of the epidermal growth factor receptor gene in human gliomas
55. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
56. Neuregulin signaling in the heart
57. Neuregulins promote survival and growth of cardiac myocytes
58. Heregulin-dependent trafficking and cleavage of ErbB-4
59. Localization of the human HER4/erbB-4 gene to chromosome 2